Compare Lupin Ltd with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs ALEMBIC LTD - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN ALEMBIC LTD LUPIN/
ALEMBIC LTD
 
P/E (TTM) x 48.4 73.7 65.7% View Chart
P/BV x 2.5 2.6 94.8% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 LUPIN   ALEMBIC LTD
EQUITY SHARE DATA
    LUPIN
Mar-19
ALEMBIC LTD
Mar-18
LUPIN/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs98672 1,369.4%   
Low Rs72034 2,125.1%   
Sales per share (Unadj.) Rs369.54.7 7,860.1%  
Earnings per share (Unadj.) Rs13.46.1 219.6%  
Cash flow per share (Unadj.) Rs37.46.2 598.6%  
Dividends per share (Unadj.) Rs00.20 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs303.740.7 746.9%  
Shares outstanding (eoy) m452.49267.03 169.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.311.3 20.5%   
Avg P/E ratio x63.68.7 733.7%  
P/CF ratio (eoy) x22.88.5 269.2%  
Price / Book Value ratio x2.81.3 215.7%  
Dividend payout %03.3 0.0%   
Avg Mkt Cap Rs m386,06414,139 2,730.4%   
No. of employees `00017.7NA-   
Total wages/salary Rs m31,513207 15,194.3%   
Avg. sales/employee Rs Th9,453.8NM-  
Avg. wages/employee Rs Th1,782.0NM-  
Avg. net profit/employee Rs Th343.0NM-  
INCOME DATA
Net Sales Rs m167,1821,255 13,319.1%  
Other income Rs m3,640370 983.3%   
Total revenues Rs m170,8221,625 10,509.5%   
Gross profit Rs m28,822111 25,942.6%  
Depreciation Rs m10,85038 28,704.0%   
Interest Rs m3,0782 181,076.5%   
Profit before tax Rs m18,534442 4,195.1%   
Minority Interest Rs m-890-   
Prior Period Items Rs m381,212 3.1%   
Extraordinary Inc (Exp) Rs m-3,4000-   
Tax Rs m9,01724 37,648.9%   
Profit after tax Rs m6,0661,630 372.2%  
Gross profit margin %17.28.9 194.8%  
Effective tax rate %48.75.4 897.4%   
Net profit margin %3.6129.8 2.8%  
BALANCE SHEET DATA
Current assets Rs m138,5361,867 7,419.8%   
Current liabilities Rs m61,299591 10,368.5%   
Net working cap to sales %46.2101.6 45.4%  
Current ratio x2.33.2 71.6%  
Inventory Days Days8494 88.9%  
Debtors Days Days11274 152.9%  
Net fixed assets Rs m127,5161,791 7,120.2%   
Share capital Rs m905534 169.4%   
"Free" reserves Rs m136,51710,324 1,322.4%   
Net worth Rs m137,42210,858 1,265.7%   
Long term debt Rs m66,41741 161,206.8%   
Total assets Rs m279,49411,591 2,411.4%  
Interest coverage x7.0260.9 2.7%   
Debt to equity ratio x0.50 12,736.9%  
Sales to assets ratio x0.60.1 552.3%   
Return on assets %3.314.1 23.2%  
Return on equity %4.415.0 29.4%  
Return on capital %8.915.2 58.7%  
Exports to sales %01.5 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA19 0.0%   
Imports (cif) Rs mNA263 0.0%   
Fx inflow Rs m59,41419 306,255.7%   
Fx outflow Rs m22,282264 8,445.9%   
Net fx Rs m37,132-244 -15,191.7%   
CASH FLOW
From Operations Rs m16,660236 7,065.2%  
From Investments Rs m-32,825-224 14,653.9%  
From Financial Activity Rs m7,441-27 -27,974.8%  
Net Cashflow Rs m-8,724-15 58,943.9%  

Share Holding

Indian Promoters % 46.6 64.0 72.8%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 0.2 5,650.0%  
FIIs % 31.9 9.7 328.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 26.1 38.7%  
Shareholders   98,259 54,701 179.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   NATCO PHARMA  PANACEA BIOTECH  CADILA HEALTHCARE  GSK PHARMA  PLETHICO PHARMA  

Compare LUPIN With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Sep 20, 2019 (Close)

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS